Preparing for tomorrow: Molecular diagnostics and the changing nonsmall cell lung cancer landscape

作者: Michael Boyer , Ming-Sound Tsao , Pasi Jänne , Suresh Ramalingam , Susan Pitman Lowenthal

DOI: 10.1111/AJCO.12189

关键词:

摘要: Over the last 10 to 15 years, the landscape of lung cancer has changed dramatically. Where cancers were previously described rather simplistically according to histological subtype, now molecular understanding of tumors has particularly resulted in segmentation of nonsmall cell lung cancer into many different subtypes. A multidisciplinary approach integrating a molecular testing algorithm that ideally includes reflex testing at diagnosis is recommended. This offers clinicians the opportunity to target treatment according to subtype …

参考文章(51)
Eugen C. Minca, Bryce P. Portier, Zhen Wang, Christopher Lanigan, Carol F. Farver, Yan Feng, Patrick C. Ma, Valeria A. Arrossi, Nathan A. Pennell, Raymond R. Tubbs, ALK Status Testing in Non–Small Cell Lung Carcinoma: Correlation Between Ultrasensitive IHC and FISH The Journal of Molecular Diagnostics. ,vol. 15, pp. 341- 346 ,(2013) , 10.1016/J.JMOLDX.2013.01.004
D. Kim, M. Ahn, P. Yang, X. Liu, T. De Pas, L. Crinò, S. Lanzalone, A. Polli, A. Shaw, Updated Results of a Global Phase II Study with Crizotinib in Advanced Alk-Positive Non-Small Cell Lung Cancer (NSCLC) Annals of Oncology. ,vol. 23, pp. 402- 402 ,(2012) , 10.1016/S0923-7534(20)33871-0
Sreenath V. Sharma, Daphne W. Bell, Jeffrey Settleman, Daniel A. Haber, Epidermal growth factor receptor mutations in lung cancer Nature Reviews Cancer. ,vol. 7, pp. 169- 181 ,(2007) , 10.1038/NRC2088
William Pao, Marc Ladanyi, Epidermal growth factor receptor mutation testing in lung cancer: searching for the ideal method. Clinical Cancer Research. ,vol. 13, pp. 4954- 4955 ,(2007) , 10.1158/1078-0432.CCR-07-1387
Sai-Hong Ignatius Ou, Eunice L. Kwak, Christina Siwak-Tapp, Joni Dy, Kristin Bergethon, Jeffrey W. Clark, D. Ross Camidge, Benjamin J. Solomon, Robert G. Maki, Yung-Jue Bang, Dong-Wan Kim, James Christensen, Weiwei Tan, Keith D. Wilner, Ravi Salgia, A. John Iafrate, Activity of crizotinib (PF02341066), a dual mesenchymal-epithelial transition (MET) and anaplastic lymphoma kinase (ALK) inhibitor, in a non-small cell lung cancer patient with de novo MET amplification. Journal of Thoracic Oncology. ,vol. 6, pp. 942- 946 ,(2011) , 10.1097/JTO.0B013E31821528D3
Neal I. Lindeman, Philip T. Cagle, Mary Beth Beasley, Dhananjay Arun Chitale, Sanja Dacic, Giuseppe Giaccone, Robert Brian Jenkins, David J. Kwiatkowski, Juan-Sebastian Saldivar, Jeremy Squire, Erik Thunnissen, Marc Ladanyi, Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology Journal of Thoracic Oncology. ,vol. 8, pp. 823- 859 ,(2013) , 10.1097/JTO.0B013E318290868F
Eunhee S. Yi, Jennifer M. Boland, Joseph J. Maleszewski, Anja C. Roden, Andre M. Oliveira, Marie-Christine Aubry, Michele R. Erickson-Johnson, Bolette L. Caron, Yan Li, Hui Tang, Shawn Stoddard, Jason Wampfler, Kimary Kulig, Ping Yang, Correlation of IHC and FISH for ALK Gene Rearrangement in Non-small Cell Lung Carcinoma: IHC Score Algorithm for FISH Journal of Thoracic Oncology. ,vol. 6, pp. 459- 465 ,(2011) , 10.1097/JTO.0B013E318209EDB9
H Asahina, , K Yamazaki, I Kinoshita, N Sukoh, M Harada, H Yokouchi, T Ishida, S Ogura, T Kojima, Y Okamoto, Y Fujita, H Dosaka–Akita, H Isobe, M Nishimura, A phase II trial of gefitinib as first-line therapy for advanced non-small cell lung cancer with epidermal growth factor receptor mutations. British Journal of Cancer. ,vol. 95, pp. 998- 1004 ,(2006) , 10.1038/SJ.BJC.6603393
Jin Ho Paik, Gheeyoung Choe, Hyojin Kim, Ji-Young Choe, Hyun Ju Lee, Choon-Taek Lee, Jong Seok Lee, Sanghoon Jheon, Jin-Haeng Chung, Screening of Anaplastic Lymphoma Kinase Rearrangement by Immunohistochemistry in Non-small Cell Lung Cancer: Correlation with Fluorescence In Situ Hybridization Journal of Thoracic Oncology. ,vol. 6, pp. 466- 472 ,(2011) , 10.1097/JTO.0B013E31820B82E8
Jing Wang, Ting-Yi Xia, Ying-Jie Wang, Hong-Qi Li, Ping Li, Ji-Dong Wang, Dong-Shu Chang, Liy-Yuan Liu, Yu-Peng Di, Xuan Wang, Wei-Zhang Wu, Prospective Study of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Concurrent With Individualized Radiotherapy for Patients With Locally Advanced or Metastatic Non–Small-Cell Lung Cancer International Journal of Radiation Oncology Biology Physics. ,vol. 81, ,(2011) , 10.1016/J.IJROBP.2010.12.035